168 related articles for article (PubMed ID: 34923043)
21. Repurposing antipsychotics of the diphenylbutylpiperidine class for cancer therapy.
Shaw V; Srivastava S; Srivastava SK
Semin Cancer Biol; 2021 Jan; 68():75-83. PubMed ID: 31618686
[TBL] [Abstract][Full Text] [Related]
22. Psychotropic use and risk of stroke among patients with bipolar disorders: 10-year nationwide population based study.
Wu CS; Wu KY; Lo YR; Huang YW; Tsai YT; Li Y; Tsai HJ
J Affect Disord; 2018 Jan; 226():77-84. PubMed ID: 28964996
[TBL] [Abstract][Full Text] [Related]
23. Tackling the Behavior of Cancer Cells: Molecular Bases for Repurposing Antipsychotic Drugs in the Treatment of Glioblastoma.
Persico M; Abbruzzese C; Matteoni S; Matarrese P; Campana AM; Villani V; Pace A; Paggi MG
Cells; 2022 Jan; 11(2):. PubMed ID: 35053377
[TBL] [Abstract][Full Text] [Related]
24. Psychotropic drug use in older people with mental illness with particular reference to antipsychotics: a systematic study of tolerability and use in different diagnostic groups.
Curran S; Turner D; Musa S; Wattis J
Int J Geriatr Psychiatry; 2005 Sep; 20(9):842-7. PubMed ID: 16116576
[TBL] [Abstract][Full Text] [Related]
25. Cannabis use in early adulthood is prospectively associated with prescriptions of antipsychotics, mood stabilizers, and antidepressants.
Rognli EB; Bramness JG; von Soest T
Acta Psychiatr Scand; 2020 Feb; 141(2):149-156. PubMed ID: 31560790
[TBL] [Abstract][Full Text] [Related]
26. Neurotransmitters, psychotropic drugs and microglia: clinical implications for psychiatry.
Kato TA; Yamauchi Y; Horikawa H; Monji A; Mizoguchi Y; Seki Y; Hayakawa K; Utsumi H; Kanba S
Curr Med Chem; 2013; 20(3):331-44. PubMed ID: 23157624
[TBL] [Abstract][Full Text] [Related]
27. Clinically significant interactions of psychotropic agents with antipsychotic drugs.
Meyer MC; Baldessarini RJ; Goff DC; Centorrino F
Drug Saf; 1996 Nov; 15(5):333-46. PubMed ID: 8941495
[TBL] [Abstract][Full Text] [Related]
28. Challenges and Promises of Pediatric Psychopharmacology.
Giles LL; Martini DR
Acad Pediatr; 2016 Aug; 16(6):508-18. PubMed ID: 27064142
[TBL] [Abstract][Full Text] [Related]
29. Induction of obesity by psychotropic drugs.
Bernstein JG
Ann N Y Acad Sci; 1987; 499():203-15. PubMed ID: 2886102
[TBL] [Abstract][Full Text] [Related]
30. What do patients learn about psychotropic medications on the web? A natural language processing study.
Hart KL; Perlis RH; McCoy TH
J Affect Disord; 2020 Jan; 260():366-371. PubMed ID: 31539672
[TBL] [Abstract][Full Text] [Related]
31. [The importance of therapeutic drug monitoring for psychotropic drugs].
Messer T; Schmauss M
MMW Fortschr Med; 2006 May; Spec no. 2():91-2, 94-5. PubMed ID: 20104722
[TBL] [Abstract][Full Text] [Related]
32. Prescription patterns for psychotropic drugs in cancer patients; a large population study in the Netherlands.
Ng CG; Boks MP; Smeets HM; Zainal NZ; de Wit NJ
Psychooncology; 2013 Apr; 22(4):762-7. PubMed ID: 22351591
[TBL] [Abstract][Full Text] [Related]
33. Cutaneous adverse reactions to psychotropic drugs: data from a multicenter surveillance program.
Lange-Asschenfeldt C; Grohmann R; Lange-Asschenfeldt B; Engel RR; Rüther E; Cordes J
J Clin Psychiatry; 2009 Sep; 70(9):1258-65. PubMed ID: 19538904
[TBL] [Abstract][Full Text] [Related]
34. The Impact of Psychotropic Medications on Bone Health in Youth.
Rice JN; Gillett CB; Malas NM
Curr Psychiatry Rep; 2018 Sep; 20(11):104. PubMed ID: 30246221
[TBL] [Abstract][Full Text] [Related]
35. Oral health impacts of medications used to treat mental illness.
Cockburn N; Pradhan A; Taing MW; Kisely S; Ford PJ
J Affect Disord; 2017 Dec; 223():184-193. PubMed ID: 28759866
[TBL] [Abstract][Full Text] [Related]
36. Characteristics and the trajectory of psychotropic medication use in general and antipsychotics in particular among adults with an intellectual disability who exhibit aggressive behaviour.
Deb S; Unwin G; Deb T
J Intellect Disabil Res; 2015 Jan; 59(1):11-25. PubMed ID: 24450426
[TBL] [Abstract][Full Text] [Related]
37. Psychotropic polypharmacy reconsidered: Between-class polypharmacy in the context of multimorbidity in the treatment of depressive disorders.
Rhee TG; Rosenheck RA
J Affect Disord; 2019 Jun; 252():450-457. PubMed ID: 31004825
[TBL] [Abstract][Full Text] [Related]
38. Psychotropic use and associated neuropsychiatric symptoms among patients with dementia in the USA.
Maust DT; Langa KM; Blow FC; Kales HC
Int J Geriatr Psychiatry; 2017 Feb; 32(2):164-174. PubMed ID: 26889640
[TBL] [Abstract][Full Text] [Related]
39. National trends in child and adolescent psychotropic polypharmacy in office-based practice, 1996-2007.
Comer JS; Olfson M; Mojtabai R
J Am Acad Child Adolesc Psychiatry; 2010 Oct; 49(10):1001-10. PubMed ID: 20855045
[TBL] [Abstract][Full Text] [Related]
40. Non-adherence with psychotropic medications in the general population.
Bulloch AG; Patten SB
Soc Psychiatry Psychiatr Epidemiol; 2010 Jan; 45(1):47-56. PubMed ID: 19347238
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
